TF Name |
Cell-line |
Condition/Source |
Collections |
Species |
Identifiers |
JASPAR ID |
GRHL2 |
MCF7 (Invasive ductal breast carcinoma) |
100nm E2 (45 min) |
Permissive
Robust
|
Homo sapiens |
GSE109820
...
|
MA1105.2
|
GRHL2 |
MCF7 (Invasive ductal breast carcinoma) |
100nm E2 (45 min) |
Permissive
Robust
|
Homo sapiens |
GSE109820
...
|
MA1105.2
|
GRHL2 |
MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant) |
Treatment: 45 min ethanol |
Permissive
Robust
|
Homo sapiens |
GSE113092
...
|
MA1105.2
|
GRHL2 |
MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant) |
Treatment: 45 min ethanol |
Permissive
Robust
|
Homo sapiens |
GSE113092
...
|
MA1105.2
|
GRHL2 |
MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant) |
Treatment: 45 min ethanol |
Permissive
Robust
|
Homo sapiens |
GSE113092
...
|
MA1105.2
|
GRHL2 |
MCF7 WS8 cells |
Treatment: 45 min ethanol |
Permissive
Robust
|
Homo sapiens |
GSE113092
...
|
MA1105.2
|
GRHL2 |
MCF7 WS8 cells |
Treatment: 45 min ethanol |
Permissive
Robust
|
Homo sapiens |
GSE113092
...
|
MA1105.2
|
GRHL2 |
MCF7 WS8 cells |
Treatment: 45 min ethanol |
Permissive
Robust
|
Homo sapiens |
GSE113092
...
|
MA1105.2
|
GRHL2 |
epiblast cells |
Origin: cell line V6.5 ESCs Treatment: grown in 2i, day 3 (GSKi and MEKi), doxycycline was added at 0.5ug/ml for 24hrs Genotype: wildtype |
Permissive
Robust
|
Mus musculus |
GSE92745
...
|
MA1105.2
|
GRHL2 |
epiblast cells |
Origin: cell line V6.5 ESCs Treatment: grown in 2i, day 3 (GSKi and MEKi), doxycycline was added at 0.5ug/ml for 24hrs Genotype: wildtype |
Permissive
Robust
|
Mus musculus |
GSE92745
...
|
MA1105.2
|
Showing 10 records in page 416
from 963 pages